OBJECTIVE: Increased levels of hypothalamic neuropeptide-Y (NPY) are thought to contribute to the manifestation of the obese phenotype. The aim of this study was to characterize the interactions between leptin, insulin and NPY in the pathogenesis of polygenic obesity. DESIGN AND METHODS: A polygenic obese animal model, the New Zealand obese mouse (NZO) and its age-matched control, was used to assess the hypothalamic mRNA expression of NPY, the insulin receptor (IR) and the leptin receptor (Ob-Rb), by semiquantitative polymerase chain reaction. Experiments were performed early (at eight weeks old) and late (at 40 weeks old) in the life of these animals. RESULTS: Serum glucose was signi®cantly elevated in obese mice. Serum insulin levels were not different between obese and lean mice, whereas serum leptin levels were signi®cantly elevated in obese mice and increased continuously during life [reaching extremely high values at 40 weeks (41.5 AE 4.1 vs 3.4 AE 0.25 ngaml for obese and lean, respectively). The hypothalamic expression of NPY mRNA was signi®cantly higher in NZO mice compared to controls at both eight weeks (2.3-fold) and 40 weeks (1.9-fold), respectively, whereas expression of IR and Ob-Rb remained unaffected. CONCLUSION: Increased hypothalamic expression of NPY due to leptin resistance, may be involved in the development of polygenic obesity. Unchanged Ob-Rb expression suggests that either a defective hypothalamic uptake or defects in Ob-Rb signalling underly this process.
Introduction
Food deprivation has been shown to increase hypothalamic expression of neuropeptide-Y (NPY), suggesting an important role of this peptide in the regulation of food intake. 1, 2 Chronic NPY administration causes severe overeating and increased body fat associated with hyperinsulinaemia and insulin resistance. 3 Also, increased NPY activity in the hypothalamus, may contribute to obesity in Zucker rats. 4 These data suggest that increased levels of hypothalamic NPY are manifestations of the obese phenotype and may, therefore, contribute to bring about their hyperphagia and increased body weight.
In contrast to NPY, the recently identi®ed product of the ob gene, leptin, acts at the level of the hypothalamus to inhibit food intake and increase energy expenditure. 5 ± 7 It exerts these effects by acting on different isoforms of its receptors 8 that are predominantly located in the hypothalamus, but are also found in other brain areas and in the periphery. 9 Another molecule involved in the regulation of energy balance is insulin. Insulin administration either directly into the brain 10 or systemically with glucose to prevent hypoglycaemia 11 suppresses food intake. Increasing evidence now suggests that insulin 12, 13 and leptin 14, 15 inhibit food intake over the long term by an action targeting hypothalamic NPY. This inhibitory action may be regulatory linked to additional neuroendocrine peptides in a complex fashion. 16 The aim of the present work was to identify the interactions between leptin, insulin and NPY in the pathogenesis of obesity, using a polygenic animal model. The New Zealand obese (NZO)aHI mouse, which is characterized by hyperphagia-associated obesity, 17 was chosen as body weight and adipose tissue mass keep increasing throughout its entire lifespan, thereby resembling the human situation of adult onset obesity. 17 Using this animal model, Igel et al 18 very recently reported leptin resistance and unaltered expression of Ob-Rb at 16 weeks of age. Our data extend these observations, suggesting that hypothalamic NPY may play an important role in the pathogenesis of obesity in NZO mice, early in life. 
Materials and methods

Chemicals
Animals
Male NZO-HI mice and age-matched lean C57BLKSJ a lean controls were bred in the Diabetes Research Institute Du Èsseldorf (Du Èsseldorf, Germany) and kindly provided by Prof. L. Herberg. All animals were submitted to a 12 h light 12 h dark cycle and supplied with standard chow food (4.5% fat; 21% protein) and water ad libitum. Animals were killed by decapitation, allowing for collection of blood. Aliquots of serum samples were stored at 7 20 C for subsequent determination of glucose, insulin (radioimmunoassay (RIA) kit, Pharmacia, Bromma, Sweden) and leptin (mouse RIA kit, Linco Research, Ko Èln, Germany).
Immediately after decapitation, the brain was rapidly excised and frozen on a cooling plate, prior to dissection of the hypothalamus. It was removed following the procedure of earlier reports in the literature. 21 Preparation of RNA and cDNA Total RNA was isolated from the hypothalamus using TRIzol reagent according to the manufacturer's instructions. For cDNA synthesis, 2 mg of total RNA and olido(dT) primer in a total volume of 10 ml were incubated for 5 min at 60 C to allow primer annealing. After cooling on ice, 8 ml of 5 Â ®rst strand synthesis buffer (250 mM Tris-HCl, 375 mM KCl, 15 mM MgCl 2 , pH 8.3), dNTP (10 mM each), 100 U of RNAseH (M-MLV) reverse transcriptase and 0.1% diethylpyrocarbonate (DEPC) water in a total volume of 30 ml, was added to the step one reaction. The reactants were mixed and incubated at 37 C for 1 h and then further incubated at 70 C for 10 min. The cDNAaRNA mixture was stored at 7 80 C.
Polymerase chain reaction (PCR)
The PCR reaction mixture was added directly to 5 ml of template cDNA, to yield ®nal concentrations of: 1 Â PCR buffer (10 mM TrisHcl, 50 mM KCl, 1.5 mM MgCl 2 , pH 8.3), 200 mM of dNTP, 0.2 mM of each primer (sense and antisense) and 1.25 U of Taq polymerase, in a ®nal volume of 50 ml. Co-ampli®cation of NPY and beta-actin was undertaken in the same tube using 94 C for 1 min, 58 C for 45 s and 72 for 1 min with 30 cycles. Ampli®cation of the insulin receptor and beta-actin was undertaken in separate tubes, using 94 C for 1 min, 58 C for 45 s and 72 C for 1 min with 30 cycles. Ob-Rb was ampli®ed using 94 C for 1 min, 55 C for 1 min and 72 C for 1 min with 30 cycles. 10 ml was withdrawn from the PCR reaction and separated in a 2% agarose gel containing ethidium bromide (Biozym, Heidelberg, Germany). Ampli®ed DNA bands were visualized with a UV transilluminator (Serva, Heidelberg, Germany).
For semiquantitative PCR, the reaction was performed in the presence of 5 mCi of [35S]dATP. An aliquot of the PCR product was subjected to polyacrylamide gel electrophoresis using the ExcelGel DNA analysis kit (Pharmacia, Freiburg, Germany). Gels were dried and analyzed on a Fujix BAS 1000 bioimaging analyser (Fuji, Mu Ènchen, Germany). 4 All data analysis was performed using Prism (GraphPad, CA) or t-ease (ISI, DC) statistical software. Signi®-cance of reported differences was evaluated using the null hypothesis and t statistics for unpaired data.
Results
Since lean controls for NZO mice are not available, 17 we have used age-matched lean C57BLKSaJ a mice. As shown in Table 1 , NZO were markedly overweight, with an even more pronounced increase in body weight in old animals. At both ages NZO were moderately hyperglycaemic, however, serum insulin concentrations were not signi®cantly different from lean controls (Table 1) . Serum leptin was signi®cantly elevated in NZO mice aged 8 weeks and increased substantially with ongoing age, reaching extremely high values at 40 weeks (41.5AE 4.1 vs 3.4 AE 0.25 ngaml for obese and lean, respectively).
RT-PCR-based ampli®cation of NPY, the insulin receptor and the leptin receptor Ob-Rb from total hypothalamic RNA of control mice, is presented in Figure 1 . Using optimized conditions, one single band was obtained for NPY (calculated fragment size 146 bp), the insulin receptor (IR, calculated fragment size 469 bp) (Figure 1, upper panel) , and for the ObRb (calculated fragment size 445 bp) (Figure 1, lower  panel) . Beta-actin was either co-ampli®ed (in case of NPY) or ampli®ed in parallel under identical conditions and all data were normalized to the intensity of the beta-actin signals. Control experiments were performed to evaluate the purity of reagents and of the RNA-preparation (see Figure 1) . Further, linear conditions for cycle number and amount of cDNA were established.
Using the conditions described above, we performed the semiquantitative determination of the NPY mRNA level in the hypothalamus of adult and old NZO mice, and compared it to lean controls ( Figure 2) . A representative autoradiogram showing PCR products, obtained from four individual animals, for each situation, is presented in Figure 2 , upper panel. As can be clearly seen, a constant level was observed for the housekeeping gene, beta-actin. However, in all experiments, the ampli®cation of NPY resulted in enhanced signals, when compared to lean controls at both ages. Quanti®cation of NPY PCRsignals, relative to beta-actin, indicated a 2.3-fold increase in the hypothalamic NPY mRNA level in * Signi®cantly different from control with P`0.05. NPY and obesity NM Rizk et al NZO mice at eight weeks of age, when compared to a lean controls and a 1.9-fold increase at 40 weeks of age. The increase in NPY mRNA level was not signi®cantly different for the two ages.
The same analysis was then carried out for the hypothalamic leptin receptor Ob-Rb and the insulin receptor. Quanti®cation of the relative mRNA expression of these receptors is presented in Figure 3 . In contrast to NPY, no signi®cant differences could be detected in adult or old NZO mice when compared to the age-matched lean controls. Thus, despite extremely high concentrations of serum leptin, a reduction in the expression of the hypothalamic leptin receptor mRNA, does not occur.
Discussion
NZO mice represent a polygenic animal model of obesity exhibiting mild hyperglycaemia, insulin resistance and a continuous increase in body weight throughout its entire lifespan. 17 As recently reported by Igel and co-workers, 18 ,22 these animals are characterized by a near 3-fold increase in body fat mass, a marked elevation of the leptin protein (with unaltered sequence) in adipose tissue and serum, and a profound leptin resistance at the age of 16 weeks. We now show that this leptin resistance is paralleled by a signi®cant increase in hypothalamic NPY gene expression over the entire lifespan of the animals. Most importantly, despite a tremendous increase in serum leptin in 40 weeks old NZO mice (12-fold over control), the upregulation of NPY remained unaffected. These data suggest that the dysregulation of NPY takes place early in life and that the underlying leptin resistance is even more pronounced with ongoing age. Our ®ndings agree with earlier reports on monogenic animal models of obesity. Thus, an increased hypothalamic mRNA level of NPY was observed in faafa Zucker rats 12, 23 and in obaob mice. 21 Given the well established role of NPY for the stimulation of food intake and suppression of energy expenditure, 24 we conclude that elevated hypothalamic NPY may be responsible for hyperphagia, development and maintenance of polygenic obesity. It should be noted that, in contrast to dbadb mice, the NZO mice represent a model of moderate hyperglycaemia and hyperinsulinaemia. 17 Plasma insulin levels in this animal model have been reported to be of remarkable variability, 25 which may explain our inability to detect hyperinsulinaemia in the NZO mice used in the present study. Furthermore, we cannot rule out defects in pancreatic b-cell function even at eight weeks of age.
In contrast to NPY, the mRNA expression of the hypothalamic leptin receptor b isoform in NZO mice was not different from lean control mice in both young and old animals. This ®nding agrees with the observations of Igel et al, 18 using a ribonuclease protection assay. RT-PCR based determinations of leptin receptor mRNA in human hypothalamus were performed by Considine et al, 26 showing a lack of correlation between leptin receptor gene expression and body mass index (BMI). In addition polymorphisms of the leptin receptor, as detected in NZO mice 18 and humans, 26 were excluded to be responsible for the obese phenotype. Therefore, a defect of leptin transport via the blood-brain barrier 27 andaor a postreceptor defect in signal transduction, 28 may induce the leptin resistance of both NZO mice and humans. It must also be considered that the present investigation does not rule out down-regulation of the leptin receptor at the protein level due to an enhanced rate of receptor degradation.
In addition to leptin, insulin has been recognized as regulating food intake and inhibiting hypothalamic NPY gene expression. 12 Interestingly, the NZO mice used in our study were not hyperinsulinaemic. This agrees with the reported remarkable variability of plasma insulin in this animal model. 17 As shown here, gene expression of the hypothalamic insulin receptor remained constant during aging and was not different between control and NZO mice. In obese Zucker rats, central administration of insulin was unable to reduce NPY mRNA expression in the NPY and obesity NM Rizk et al arcuate nucleus, suggesting that insulin resistance at the level of hypothalamic insulin receptors may contribute to the development of obesity in this animal model. 29 For the polygenic NZO mice, this possibility cannot be ruled out at the present stage. However, it seems less likely since a) expression of the IR is normal, and b) NZO mice are only moderately insulin resistant, as seen from the mild hyperglycaemia and the normoinsulinaemia. Further work will be needed to clarify the role of insulin and insulin receptors for the development of polygenic obesity.
Conclusion
Our results suggest that increased hypothalamic mRNA levels of NPY contribute to hyperphagia and the development of obesity in NZO mice. Dysregulation of NPY mostly re¯ects leptin resistance, which increases with ongoing age. Defects distal to the leptin receptor may play an important role in the development of obesity early in life and in the maintenance of the syndrome in the elderly.
